Skip to main content

ADVERTISEMENT

EVAR

Interview
12/18/2023
We spoke with Dr. Adam Beck to discuss how these organizations are working together to improve EVAR.
We spoke with Dr. Adam Beck to discuss how these organizations are working together to improve EVAR.
We spoke with Dr. Adam Beck to...
12/18/2023
Vascular Disease Management
Review
12/14/2022
This article provides a contemporary appraisal of the literature regarding the evolution of endovascular therapy for complex aortic disease and future directions.
This article provides a contemporary appraisal of the literature regarding the evolution of endovascular therapy for complex aortic disease and future directions.
This article provides a...
12/14/2022
Vascular Disease Management
Video
08/15/2022
In this interview, Frank Arko, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Atrium Health discusses his use of IVL to maintain transfemoral EVAR/TEVAR access in patients with calcified vessels. Dr....
In this interview, Frank Arko, MD, Chief of Vascular and Endovascular Surgery at Sanger Heart and Vascular Institute, Atrium Health discusses his use of IVL to maintain transfemoral EVAR/TEVAR access in patients with calcified vessels. Dr....
In this interview, Frank Arko,...
08/15/2022
Vascular Disease Management
Video
06/01/2022
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR...
06/01/2022
Vascular Disease Management
Original Contribution
08/01/2021
The purpose of this analysis was to examine the association of iso-osmolar contrast media vs low-osmolar contrast media with major adverse renal or cardiovascular events in patients at high risk of AKI undergoing EVAR.
The purpose of this analysis was to examine the association of iso-osmolar contrast media vs low-osmolar contrast media with major adverse renal or cardiovascular events in patients at high risk of AKI undergoing EVAR.
The purpose of this analysis was...
08/01/2021
Journal of Invasive Cardiology
Cover Story
04/24/2019
Despite numerous advantages, vascular complications associated with percutaneous access can occur during and after TAVR, and increase morbidity and mortality significantly. Effective management of potentially catastrophic vascular...
Despite numerous advantages, vascular complications associated with percutaneous access can occur during and after TAVR, and increase morbidity and mortality significantly. Effective management of potentially catastrophic vascular...
Despite numerous advantages,...
04/24/2019
Journal of Invasive Cardiology
Interview
09/11/2018
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM,...
09/11/2018
Vascular Disease Management
Review
05/29/2012
EVAR is considered relatively safe and effective for treating infrarenal AAA. In patients with favorable anatomy, it is widely considered the therapy of choice among clinicians. The indications for EVAR are expanding, particularly in...
EVAR is considered relatively safe and effective for treating infrarenal AAA. In patients with favorable anatomy, it is widely considered the therapy of choice among clinicians. The indications for EVAR are expanding, particularly in...
EVAR is considered relatively...
05/29/2012
Vascular Disease Management